✦ LIBER ✦

Enhanced Replication of R5 HIV-1 Isolates in vitro by a Small-Molecule Reagent Targeting HIV-1 Protease

✍ Scribed by Wardle, Nick J.; Hudson, Harry R.; Matthews, Ray W.; Nunn, Christine M.; Vella, Cherelyn; Bligh, S. W. Annie

Book ID: 120355750
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 267 KB
Volume: 8
Category: Article
ISSN: 1860-7179
DOI: 10.1002/cmdc.201300051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sustained and specific in vitro inhibiti

Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes

✍ Reginald Clayton; Asa Ohagen; Francois Nicol; Alfred M. Del Vecchio; Tim H.M. Jo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 919 KB

Differential Use of CCR5 by HIV-1 Clinic

Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists

✍ Henrich, T. J.; Lewine, N. R. P.; Lee, S.-H.; Rao, S. S. P.; Berro, R.; Gulick, 📂 Article 📅 2012 🏛 American Society for Microbiology 🌐 English ⚖ 755 KB

Clastogenic Factors In Plasma Of HIV-1 I

Clastogenic Factors In Plasma Of HIV-1 Infected Patients Activate HIV-1 Replication In Vitro: Inhibition By Superoxide Dismutase

✍ Marvin A. Edeas; Ingrid Emerit; Yacine Khalfoun; Yamina Lazizi; Lidia Cernjavski 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Small molecule inhibitor of HIV-1 nuclea

Small molecule inhibitor of HIV-1 nuclear import suppresses HIV-1 replication in human lymphoid tissue ex vivo: a potential addition to current anti-HIV drug repertoire

✍ Svetlana Glushakova; Larisa Dubrovsky; Jean-Charles Grivel; Omar Haffar; Michael 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 160 KB

In vitro and in vivo prevention of HIV p

In vitro and in vivo prevention of HIV protease inhibitor-induced insulin resistance by a novel small molecule insulin receptor activator

✍ Mingshan Cheng; Seiyu Chen; Steven R. Schow; Vara Prasad Manchem; Wayne R. Speva 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

## Abstract Protease inhibitor (PI) therapy for the treatment of patients infected with human immunodeficiency virus is frequently associated with insulin resistance and diabetic complications. These adverse effects of PI treatment result to a large extent from their inhibition of insulin‐stimulate

Potent and selective inhibition of HIV-1

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

✍ Pauwels, Rudi; Andries, Koen; Desmyter, Jan; Schols, Dominique; Kukla, Michael J 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 538 KB